Disseminated porokeratosis transiently healed by cancer chemotherapy

European Journal of Dermatology

Volumn 24, Issue 2, 2014, Pages 260-261

  Breton, Anne Laure ^a   Pralong, Pauline ^a   Trillet Lenoir, Véronique ^a   Balme, Brigitte ^a   Nicolas, Jean François ^a   Berard, Frédéric ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; MIDDLE AGED; OVARY CANCER; POROKERATOSIS; SKIN BIOPSY; SKIN DEFECT; REMISSION;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MIDDLE AGED; POROKERATOSIS; REMISSION INDUCTION;

EID: 84901278249     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2014.2289     Document Type: Article

References (9)

1. Kanitakis J, Euvrard S, Faure M, Claudy A. Porokeratosis and immunosuppression. Eur J Dermatol 1998; 8: 459-65.
2. Marque M, Meunier L. Porokeratosis. Ann Dermatol Venereol 2012; 139: 668-76.
3. Lee H-W, Oh S-H, Choi J-C, et al. Disseminated superficial porokeratosis in a patient with cholangiocarcinoma. J Am Acad Dermatol 2006; 54 (2 Suppl): S56-8.
4. Torres T, Velho GC, Selores M. Disseminated superficial porokeratosis in a patient with cholangiocarcinoma: a paraneoplastic manifestation? An Bras Dermatol 2010; 85: 229-31.
5. Cannavó SP, Borgia F, Adamo B, Guarneri B. Simultaneous development and parallel course of disseminated superficial porokeratosis and ovarian cancer: Coincidental association or true paraneoplastic syndrome? J Am Acad Dermatol 2008; 58: 657-60.
6. Kono T, Kobayashi H, Ishii M, Nishiguchi S, Taniguchi S. Synchronous development of disseminated superficial porokeratosis and hepatitis C virus-related hepatocellular carcinoma. J Am Acad Dermatol 2000; 43(5 Pt 2): 966-8.
7. Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001; 357: 96-100.
8. Magee JW, McCalmont TH, LeBoit PE. Overexpression of p53 tumor suppressor protein in porokeratosis. Arch Dermatol 1994; 130: 187-90.
9. Arnold SM, Regine WF, Ahmed MM, et al. Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm. Int J Radiat Oncol Biol Phys 2004; 58: 1411-7.